Control Bionics (CBL) Stock Price, News & Analysis

Company Overview

Control Bionics Limited, together with its subsidiaries, engages in the research, development, commercialization, and sale of assistive communications technology systems in Australia and North America. The company offers NeuroNode Trilogy and NeuroNode3 systems that allow people with speech and movement difficulties to control a computer for speech generation, electronic communications, entertainment, and external control of other devices. It also provides Cosmos Connect, a small portable control device that can be used with a Windows display device; NeuroNode, a wireless wearable sensor that gives the user the ability to access their technology by bioelectric signals or spatial movements; Uno Touch, a speech generating device; NeuroNode Duo, a wireless sensor; and Eye gaze Duo that allows the user to control a computer mouse with their eyes. The company was formerly known as Control Bionics Holdings Pty Limited and changed its name to Control Bionics Limited in September 2020. Control Bionics Limited was incorporated in 2005 and is based in Camberwell, Australia.

Key Stats

• Today's Range: N/A
• 50-Day Range: N/A
• 52-Week Range: N/A
• Volume: N/A
• Average Volume: N/A
• Market Capitalization: A$12.60 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Industry, Sector and Symbol

• Stock Exchange: ASX
• Sector: Medical
• Industry: Medical Devices
• Sub-Industry: Trading
• Current Symbol: ASX:CBL
• CIK: N/A
• Web: www.controlbionics.com
• Phone: 61 3 9897 3576
• Fax: N/A
• Employees: 460
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): A($0.04)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -A$5.91 million
• Net Margins: -110.52%
• Pretax Margin: N/A
• Return on Equity: -84.65%
• Return on Assets: -41.41%

Debt

• Debt-to-Equity Ratio: 15.34
• Current Ratio: 1.57
• Quick Ratio: 5.65

Sales & Book Value

• Annual Sales: A$5.35 million
• Price / Sales: 0.00
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: A$0.03 per share
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 247,560,000
• Free Float: N/A
• Market Cap: A$12.60 million
• Optionable: Not Optionable
• Beta: 0.15